[{"Assets_0_Q3_USD":385478000.0,"CommonStockSharesOutstanding_0_Q3_shares":51262007.0,"EarningsPerShareBasic_3_Q3_USD":0.86,"EarningsPerShareBasic_1_Q3_USD":0.31,"EarningsPerShareDiluted_3_Q3_USD":0.82,"EarningsPerShareDiluted_1_Q3_USD":0.29,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":78305000.0,"NetIncomeLoss_3_Q3_USD":43626000.0,"NetIncomeLoss_1_Q3_USD":15961000.0,"StockholdersEquity_0_Q3_USD":251663000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":53227433.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":53628389.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":50583726.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":51046375.0,"Ticker":"SUPN","CIK":"1356576","name":"SUPERNUS PHARMACEUTICALS INC","OfficialName":"Supernus Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1557812380.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20171109"}]